Medicxi Ventures Management (Jersey) Ltd
Medicxi Ventures Management (Jersey) Ltd latest Q4_2020 13F filings reported $172,068,000 in market value on this 2021-02-12 report date . The portfolio quarterly return is -17.83%. This fund has 5 securities concentrations of 100% weights.
Medicxi Ventures Management (Jersey) Ltd largest holding is Phathom Pharmaceuticals Inc. with weight of 39.92% and $68,694,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.
Portfolio Performance History
|FILE DATE||REPORT PERIOD||QTR YEAR||FILE TYPE||NOS. OF STOCKS||REPORTED VALUE||RETURN|